Background
==========

There is an epidemic of obesity and Type-2 Diabetes Mellitus (T2DM) in the developed world. Subclinical diastolic dysfunction in diabetes is associated with the development of overt heart failure. Although diabetic cardiomyopathy is well documented in older adults with T2DM there are scarce data on younger adults and no published CMR data. We aimed to assess the prevalence and potential mechanisms of subclinical left ventricular (LV) dysfunction in young T2DM adults compared to healthy lean (LC) and obese controls (OC).

Methods
=======

40 subjects (20 T2DM \[mean T2DM duration 4.7±4.0years\], 10 OC, 10 LC) underwent CMR assessment on a Siemens Avanto 1.5T system. LV function and volumes were assessed using SSFP. Circumferential strain was assessed using a high temporal-resolution CSPAMM tagging sequence at 3 slices (basal, mid-cavity, apical). Rest and stress perfusion was assessed quantitatively for perfusion defects and by calculating myocardial perfusion reserve (MPR) using model independent deconvolution at 3 slices. In a subset of the cohort (11 T2DM, 9 OC and 6 LC) T1 mapping with heart-rate correction in a single short-axis slice was performed using a Modified Look-Locker Inversion Recovery (MOLLI) sequence before and 16 minutes post administration of 0.2mmol/kg of Gadovist. Aortic distensibility was assessed on high temporal-resolution gradient echo images.

Results
=======

Subjects were well matched for age, height, blood pressure and time of T1 assessment post contrast. Global peak early diastolic strain rate (PEDSR) was significantly lower in T2DM, compared with LC and OC (see table [1](#T1){ref-type="table"}). Two patients and 1 OC had evidence of mid-wall late gadolinium enhancement (see figure [1](#F1){ref-type="fig"}). There was a trend towards concentric remodelling in OC and T2DM associated with significantly reduced PEDSR, particularly in T2DM. There was no regional perfusion defect in any subjects to suggest epicardial coronary artery disease and MPR was similar between the groups. T2DM showed no significant correlation between PEDSR and intracardiac (LV mass, Partition Coefficient of myocardium-blood contrast, MPR), vascular (aortic distensibility), anthropometric (BMI, waist:hip ratio) or metabolic (serum triglycerides, HbA1c, high-sensitivity CRP) markers. However duration of diabetes did inversely relate to PEDSR (r=-0.534, p=0.015).

###### 

CMR and anthropometric data for the 3 study groups (OC, LC, T2DM)

  Variable (mean±SD)                       Lean control (LC) (n=10)   Obese control (OC) (n=10)   Type-2 diabetes (T2DM) (n=20)   T2DM v LC (p)\*   T2DM v OC (p)\*
  ---------------------------------------- -------------------------- --------------------------- ------------------------------- ----------------- -----------------
  Age (years)                              30.0±6.6                   30.9±5.6                    31.8±6.6                        0.871             0.862
                                                                                                                                                    
  Sex (no. M:F)                            5:5                        6:4                         9:11                            0.804             0.456
                                                                                                                                                    
  BMI (kg/m2)                              21.92±1.71                 33.25±2.55                  33.86±5.80                      \<0.001           0.240
                                                                                                                                                    
  BP (mmHg)                                131/80±14/12               130/84±15/9                 137/88±15/10                    0.239             0.255
                                                                                                                                                    
  LVEDM/vol (g/ml)                         0.45 (0.42-0.51)           0.54 (0.48-0.60)            0.54 (0.45-0.61)                0.052             0.816
                                                                                                                                                    
  LVEF (%)                                 55.50±3.53                 53.64±4.46                  54.85±5.05                      0.727             0.481
                                                                                                                                                    
  PEDSR (1/s) (n for analysis)             1.80±0.47 (n=9)            1.59±0.32 (n=9)             1.27±0.34 (n=16)                0.006             0.026
                                                                                                                                                    
  Global MPR                               3.68±1.57                  3.03±0.75                   3.57±1.08                       0.927             0.270
                                                                                                                                                    
  Partition Coefficient (n for analysis)   0.443±0.05 (n=6)           0.442±0.06 (n=9)            0.443±0.06 (n=11)               0.112             0.778

![DE imaging short-axis slice (left) and three-chamber long-axis slice (right) in T2DM subject demonstrating significant focal mid-wall enhancement indicative of fibrosis, highlighting the presence of cardiac dysfunction in young diabetics (in this case, the subject had been diabetic for 6 years)](1532-429X-15-S1-O48-1){#F1}

Conclusions
===========

This study does not suggest that obesity, ischaemia, microvascular dysfunction or diffuse myocardial fibrosis are the main mechanisms contributing to subclinical diastolic dysfunction in young adults with T2DM. Duration of T2DM was strongly associated with diastolic dysfunction. Young onset T2DM is likely to result in a very high lifetime risk of cardiovascular events and heart failure.
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